Frontiers | Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis
1 Department of Neurology, Affiliated Hospital of Nantong University, Nantong, China 2 Medical School of Nantong University, Nantong, China Background: Ischemic stroke is the second leading cause of death and the third leading cause of combine d disability and mortality globally. While reperfusion therapies play a critical role in the management of acute ischemic stroke (AIS), their applicability is limited, leaving many patients with significant neurological deficits and poor prognoses. Neuroprotective